{"id":"https://openalex.org/W4301378690","doi":null,"title":"Interruptions in supplies of second-line antituberculosis drugs--United States, 2005-2012.","display_name":"Interruptions in supplies of second-line antituberculosis drugs--United States, 2005-2012.","publication_year":2013,"publication_date":"2013-01-18","ids":{"openalex":"https://openalex.org/W4301378690","pmid":"https://pubmed.ncbi.nlm.nih.gov/23325352","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4604838"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4604838","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4604838","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MMWR Morb Mortal Wkly Rep","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4604838","any_repository_has_fulltext":true},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6804,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73350732,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"62","issue":"2","first_page":"23","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/second-line-anti-tuberculosis-drugs","display_name":"second-line antituberculosis drugs","score":0.9480000138282776},{"id":"https://openalex.org/keywords/drug-shortages","display_name":"drug shortages","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multidrug-resistant-tuberculosis","display_name":"multidrug-resistant tuberculosis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/extensively-drug-resistant-tuberculosis","display_name":"extensively drug-resistant tuberculosis","score":1.0},{"id":"https://openalex.org/keywords/pharmaceutical-procurement","display_name":"drug procurement","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-interruption","display_name":"treatment interruption","score":0.6179999709129333},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5189999938011169},{"id":"https://openalex.org/keywords/drug-stockpiling","display_name":"drug stockpiling","score":0.6140000224113464},{"id":"https://openalex.org/keywords/state-and-local-health-departments","display_name":"state and local health departments","score":0.6729999780654907},{"id":"https://openalex.org/keywords/tuberculosis-control-program","display_name":"tuberculosis control program","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8660690188407898},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.7407788038253784},{"id":"https://openalex.org/C194051981","wikidata":"https://www.wikidata.org/wiki/Q1337691","display_name":"Economic shortage","level":3,"score":0.6423678398132324},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4755553603172302},{"id":"https://openalex.org/C201650216","wikidata":"https://www.wikidata.org/wiki/Q829492","display_name":"Procurement","level":2,"score":0.468443900346756},{"id":"https://openalex.org/C2777107064","wikidata":"https://www.wikidata.org/wiki/Q1040214","display_name":"Extensively drug-resistant tuberculosis","level":4,"score":0.4678680896759033},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.41622626781463623},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.37541282176971436},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3429066836833954},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2586630582809448},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.22896969318389893},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.12943175435066223},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.11978107690811157},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.09386441111564636},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000600","qualifier_name":"supply & distribution","is_major_topic":true},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019538","descriptor_name":"Health Care Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054908","descriptor_name":"Extensively Drug-Resistant Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:4604838","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4604838","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MMWR Morb Mortal Wkly Rep","raw_type":"Text"},{"id":"pmid:23325352","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23325352","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MMWR. Morbidity and mortality weekly report","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4604838","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4604838","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MMWR Morb Mortal Wkly Rep","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4298268056","https://openalex.org/W2007690208","https://openalex.org/W2326407974","https://openalex.org/W4395080112","https://openalex.org/W2406191748","https://openalex.org/W2517415340","https://openalex.org/W2117326865","https://openalex.org/W2463995325","https://openalex.org/W4390588365","https://openalex.org/W4387660172"],"abstract_inverted_index":{"Second-line":[0],"drugs":[1,250,257],"(SLDs)":[2],"are":[3],"essential":[4],"for":[5,53,68,244,268],"treating":[6],"multidrug-resistant":[7],"and":[8,14,31,93,105,133,185,261,274,296,304],"extensively":[9],"drug-resistant":[10,119],"tuberculosis":[11],"(MDR":[12],"TB*":[13],"XDR":[15],"TB\u2020).":[16],"Drug":[17,32],"shortages,":[18],"in":[19,48,58],"which":[20,140],"supplies":[21],"of":[22,27,51,66,70,78,110,118,129,137,145,154,182,218,234,264,292],"all":[23],"clinically":[24],"interchangeable":[25],"versions":[26],"a":[28,75,186,225,280],"given":[29],"Food":[30],"Administration":[33],"(FDA)-regulated":[34],"drug":[35,56,111,131,194,269],"become":[36],"inadequate":[37,236],"to":[38,99,191,208,271,277,286],"meet":[39],"actual":[40],"or":[41,204,228,231],"projected":[42],"user":[43],"demand,":[44],"have":[45,62],"been":[46],"well-documented":[47],"many":[49],"areas":[50],"medicine;":[52],"several":[54],"years,":[55],"shortages":[57,92,132,176,247,273,276],"the":[59,64,84,108,116,126,135,146,155,199,232,290,305],"United":[60],"States":[61],"affected":[63],"availability":[65],"SLDs":[67,100,253,287],"treatment":[69,222,226],"TB.":[71],"In":[72],"November":[73],"2010,":[74],"nationwide":[76,175],"survey":[77],"TB":[79,130,157,161],"control":[80],"programs":[81],"conducted":[82],"by":[83,215],"National":[85],"Tuberculosis":[86],"Controllers":[87],"Association":[88],"(NTCA)":[89],"indicated":[90,141],"that":[91,96,138,142],"other":[94,205],"problems":[95,206],"hinder":[97],"access":[98,285],"interfere":[101],"with":[102,171,210,221],"patient":[103],"care":[104],"could":[106],"promote":[107],"development":[109],"resistance":[112],"as":[113,115,198],"well":[114],"transmission":[117],"Mycobacterium":[120],"tuberculosis.":[121],"This":[122],"report":[123,272],"focuses":[124],"on":[125],"growing":[127],"issue":[128],"summarizes":[134],"findings":[136],"survey,":[139],"26":[143],"(79%)":[144],"33":[147],"responding":[148],"health":[149,298,301],"departments,":[150,299],"representing":[151],"approximately":[152],"75%":[153],"U.S.":[156],"burden,":[158],"reported":[159,214],"MDR":[160],"during":[162],"2005-2010.":[163],"Of":[164],"these":[165],"26,":[166],"21":[167,219],"(81%)":[168],"faced":[169],"difficulties":[170,209],"SLD":[172,211,246],"procurement,":[173],"citing":[174],"(100%),":[177],"shipping":[178],"delays":[179],"(71%),":[180],"lack":[181],"resources":[183],"(62%),":[184],"complicated":[187],"procurement":[188,212],"process":[189],"related":[190,207],"investigational":[192],"new":[193,265],"(IND)":[195],"protocols":[196],"(48%)":[197],"main":[200],"reasons.":[201],"Adverse":[202],"outcomes":[203],"were":[213],"19":[216],"(90%)":[217],"jurisdictions,":[220,255],"delay":[223],"(58%),":[224],"lapse":[227],"interruption":[229],"(32%),":[230],"use":[233],"an":[235],"regimen":[237],"(32%)":[238],"most":[239],"commonly":[240],"reported.":[241],"Potential":[242],"solutions":[243],"alleviating":[245],"include":[248],"stockpiling":[249],"centrally,":[251],"sharing":[252],"among":[254],"obtaining":[256],"from":[258],"foreign":[259],"manufacturers,":[260],"taking":[262],"advantage":[263],"legal":[266],"requirements":[267],"suppliers":[270],"impending":[275],"FDA":[278],"within":[279],"specified":[281],"timeframe.":[282],"Reliable,":[283],"consistent":[284],"will":[288],"require":[289],"collaboration":[291],"CDC,":[293],"FDA,":[294],"state":[295],"local":[297],"national":[300],"professional":[302],"societies,":[303],"pharmaceutical":[306],"industry.":[307]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2022-10-05T00:00:00"}